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The Federation of Biochemical Societies is one of the largest organisations in European life sciences, with more than 40 000
members distributed among 40 Constituent and Associated Societies throughout Europe.
FEBS seeks to promote, encourage and support biochemistry, molecular cell biology and molecular biophysics throughout
Europe in a variety of di¡erent ways, through a wide portfolio of activities. We fund advanced courses, provide various types of
fellowships, publish primary research through our publications (FEBS Letters and the European Journal of Biochemistry), facilitate
the exchange of information at our annual Congress, and award prizes and medals in recognition of scienti¢c distinction.
Apart from being active in supporting the career of young scientists, women in science ^ via various working groups and
committees ^, we also support our colleagues in Central and Eastern Europe, e.g. by distributing surplus research materials via our
Constituent Societies.
At this year’s FEBS Council meeting, which took place in Istanbul on October 25, 2002, it was decided to expand the activities
of FEBS, by establishing a Working Group that will be actively engaged in the realisation of the European Research Area (ERA).
ERA, a vision championed by Commissioner Phillippe Busquin, was endorsed by the member countries at the European Council
meeting in Lisbon in June 2000. At this particular meeting, the European Union (EU) Heads of Governments agreed to make the
EU the most competitive and dynamic knowledge based economy in the world, capable of sustained economic growth providing more
and better jobs and greater social cohesion. In addition, it was agreed that research activities at national and EU level must be better
integrated and co-ordinated to make them as e⁄cient and innovative as possible, and to ensure that Europe o¡ers attractive prospects
to the best brains.
Instruments to achieve ERA comprise so far the EU Framework Programme 6 (FP6), and a potential European Research
Council (ERC1) that was discussed thoroughly at a recent conference in Copenhagen organised by the Danish Presidency of the
EU2. The purpose of this conference was to de¢ne the aims and needs of European research, to look at the pros and cons of
establishing an ERC, and to discuss the options and alternatives. Speci¢c points that were discussed included the mission of an
ERC, funding instruments and research areas, as well as links to the existing research funding structure.
A majority of the conference attendees agreed that it was essential to have an ERC, and a summary of the main points raised at
can be found on http://www.forsk.dk/dkeuformand/erc_main_points.pdf. The conclusions drawn at the meeting will be sent to
Helge Sander, Danish Minister of Science, Technology and Innovation, who will inform the Competitiveness Council on No-
vember 26, 2002. It is expected that the Greek Presidency of the EU will follow up on the discussions early next year.
To ensure the participation of the scienti¢c community in the initial stages of the ERC discussions, FEBS, the European
Molecular Biology Organisation (EMBO), and the European Life Sciences Forum (ELSF) will host a joint meeting on February
18^19, 2003 to discuss the need and priorities of the ERC initiative. The meeting will take place in Paris, under the auspices of
UNESCO.
The window of opportunity is narrow, and therefore we must make all e¡orts to transform the ERC idea into an active political
object.
Julio E. Celis
Secretary General of FEBS
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1 ERC could mean one or several research councils.
2 ‘Do we need a European Research Council?’ Copenhagen, October 7^8, 2002.
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